ARGAN INC (AGX) — insider trading
Industrials · NYSE
ARGAN INC (AGX) has 38 reported SEC Form 4 insider transactions in our data, including 11 open-market sales among the most recent 38 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Jeffrey John Ronald Jr. | Director | Option exercise / conversion (derivative) | 1,000 | $43.70 | $43.7K | Form 4 |
| 2026-06-30 | Jeffrey John Ronald Jr. | Director | Option exercise / conversion (derivative) | 5,000 | $35.72 | $178.6K | Form 4 |
| 2026-06-30 | Jeffrey John Ronald Jr. | Director | Option exercise / conversion | 944 | $43.70 | $41.3K | Form 4 |
| 2026-06-30 | Jeffrey John Ronald Jr. | Director | Option exercise / conversion | 4,772 | $35.72 | $170.5K | Form 4 |
| 2026-06-22 | Griffin William F Jr | Director, Other | Open-market sale | 20,000 | $760.43 | $15.21M | Form 4 |
| 2026-06-18 | Griffin William F Jr | Director, Other | Open-market sale | 30,000 | $725.85 | $21.78M | Form 4 |
| 2026-06-17 | Baugher Joshua Scott | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 1,000 | $61.22 | $61.2K | Form 4 |
| 2026-06-17 | Baugher Joshua Scott | Officer (Chief Financial Officer) | Open-market sale | 305 | $734.00 | $223.9K | Form 4 |
| 2026-06-17 | Baugher Joshua Scott | Officer (Chief Financial Officer) | Open-market sale | 455 | $732.83 | $333.4K | Form 4 |
| 2026-06-17 | Baugher Joshua Scott | Officer (Chief Financial Officer) | Option exercise / conversion | 455 | $61.22 | $27.9K | Form 4 |
| 2026-06-17 | Getsinger Peter W | Director | Open-market sale | 2,000 | $699.00 | $1.40M | Form 4 |
| 2026-06-17 | Sweeney Karen | Director | Open-market sale | 300 | $705.00 | $211.5K | Form 4 |
| 2026-06-16 | Getsinger Peter W | Director | Open-market sale | 4,728 | $708.65 | $3.35M | Form 4 |
| 2026-06-16 | Watson David Hibbert | Director, Officer (PRESIDENT AND CEO) | Option exercise / conversion (derivative) | 667 | $148.72 | $99.2K | Form 4 |
| 2026-06-16 | Watson David Hibbert | Director, Officer (PRESIDENT AND CEO) | Option exercise / conversion (derivative) | 1,000 | $61.22 | $61.2K | Form 4 |
| 2026-06-16 | Watson David Hibbert | Director, Officer (PRESIDENT AND CEO) | Option exercise / conversion (derivative) | 1,666 | $39.47 | $65.8K | Form 4 |
| 2026-06-16 | Watson David Hibbert | Director, Officer (PRESIDENT AND CEO) | Open-market sale | 1,880 | $707.35 | $1.33M | Form 4 |
| 2026-06-16 | Watson David Hibbert | Director, Officer (PRESIDENT AND CEO) | Option exercise / conversion | 430 | $148.72 | $63.9K | Form 4 |
| 2026-06-16 | Watson David Hibbert | Director, Officer (PRESIDENT AND CEO) | Option exercise / conversion | 588 | $61.22 | $36.0K | Form 4 |
| 2026-06-16 | Watson David Hibbert | Director, Officer (PRESIDENT AND CEO) | Option exercise / conversion | 862 | $39.47 | $34.0K | Form 4 |
| 2026-06-15 | Getsinger Peter W | Director | Option exercise / conversion (derivative) | 5,000 | $35.72 | $178.6K | Form 4 |
| 2026-06-15 | Getsinger Peter W | Director | Option exercise / conversion | 4,728 | $35.72 | $168.9K | Form 4 |
| 2026-06-15 | Watson David Hibbert | Director, Officer (PRESIDENT AND CEO) | Open-market sale | 9,993 | $651.22 | $6.51M | Form 4 |
| 2026-06-15 | Flanders Cynthia | Director | Open-market sale | 2,596 | $666.31 | $1.73M | Form 4 |
| 2026-06-12 | Griffin William F Jr | Director, Other | Open-market sale | 50,000 | $643.46 | $32.17M | Form 4 |
| 2026-06-10 | Jeffrey John Ronald Jr. | Director | Grant / award / vesting (derivative) | 189 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Jeffrey John Ronald Jr. | Director | Option exercise / conversion (derivative) | 530 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Jeffrey John Ronald Jr. | Director | Option exercise / conversion | 533 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Leimkuhler William F. | Director | Grant / award / vesting (derivative) | 189 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Leimkuhler William F. | Director | Option exercise / conversion (derivative) | 530 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Leimkuhler William F. | Director | Option exercise / conversion | 533 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Sweeney Karen | Director | Grant / award / vesting (derivative) | 189 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Sweeney Karen | Director | Option exercise / conversion (derivative) | 530 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Sweeney Karen | Director | Option exercise / conversion | 533 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Flanders Cynthia | Director | Grant / award / vesting (derivative) | 189 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Flanders Cynthia | Director | Option exercise / conversion (derivative) | 530 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Flanders Cynthia | Director | Option exercise / conversion | 533 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Flanders Cynthia | Director | Bona fide gift | 1,000 | $0.00 | $0 | Form 4 |
Ask the chat about AGX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ARGAN INC (AGX).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.